FR2984743B1 - Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses. - Google Patents

Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.

Info

Publication number
FR2984743B1
FR2984743B1 FR1162394A FR1162394A FR2984743B1 FR 2984743 B1 FR2984743 B1 FR 2984743B1 FR 1162394 A FR1162394 A FR 1162394A FR 1162394 A FR1162394 A FR 1162394A FR 2984743 B1 FR2984743 B1 FR 2984743B1
Authority
FR
France
Prior art keywords
steviol
stimulating
restoring
isomers
semi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1162394A
Other languages
English (en)
Other versions
FR2984743A1 (fr
Inventor
Julien Laboureau
Myriam Kauffmann
Yann Mahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1162394A priority Critical patent/FR2984743B1/fr
Priority to EP12824722.8A priority patent/EP2793821B1/fr
Priority to PCT/IB2012/057614 priority patent/WO2013093881A1/fr
Priority to ES12824722T priority patent/ES2901692T3/es
Priority to CN201280070622.0A priority patent/CN104125822B/zh
Priority to US14/368,212 priority patent/US9687434B2/en
Publication of FR2984743A1 publication Critical patent/FR2984743A1/fr
Application granted granted Critical
Publication of FR2984743B1 publication Critical patent/FR2984743B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne l'utilisation cosmétique du steviol, d'un dérivé glycoside du steviol, ou un de leurs isomères, pour stimuler, restaurer ou réguler le métabolisme de cellules de la peau.
FR1162394A 2011-12-23 2011-12-23 Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses. Active FR2984743B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1162394A FR2984743B1 (fr) 2011-12-23 2011-12-23 Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.
EP12824722.8A EP2793821B1 (fr) 2011-12-23 2012-12-21 Utilisation cosmétique du rebaudioside a en tant que dérivé du glycoside de stéviol ou de l'un de ses stéréoisomères par voie topique externe pour prévenir et/ou traiter les signes de vieillissement de la peau ou des semi-muqueuses
PCT/IB2012/057614 WO2013093881A1 (fr) 2011-12-23 2012-12-21 Utilisation cosmétique du stéviol, d'un dérivé glycoside de stéviol, ou d'un de leurs isomères pour stimuler, restaurer ou réguler le métabolisme des cellules de la peau et des membranes semi-muqueuses
ES12824722T ES2901692T3 (es) 2011-12-23 2012-12-21 Uso cosmético de rebaudiósido A como derivado de glucósido de esteviol o de uno de sus estereoisómeros por vía tópica externa para prevenir y/o tratar los signos del envejecimiento de la piel o de las membranas semimucosas
CN201280070622.0A CN104125822B (zh) 2011-12-23 2012-12-21 甜菊醇、甜菊醇糖苷衍生物或其异构体之一用于刺激、修复或调节皮肤和半粘膜的细胞新陈代谢的美容用途
US14/368,212 US9687434B2 (en) 2011-12-23 2012-12-21 Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1162394A FR2984743B1 (fr) 2011-12-23 2011-12-23 Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.

Publications (2)

Publication Number Publication Date
FR2984743A1 FR2984743A1 (fr) 2013-06-28
FR2984743B1 true FR2984743B1 (fr) 2014-08-22

Family

ID=46275881

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1162394A Active FR2984743B1 (fr) 2011-12-23 2011-12-23 Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.

Country Status (6)

Country Link
US (1) US9687434B2 (fr)
EP (1) EP2793821B1 (fr)
CN (1) CN104125822B (fr)
ES (1) ES2901692T3 (fr)
FR (1) FR2984743B1 (fr)
WO (1) WO2013093881A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9822489B2 (en) 2011-10-28 2017-11-21 TaylorBaby, LLC Flavored wipe and dispensing system
US11730683B2 (en) 2011-10-28 2023-08-22 TaylorBaby, LLC Flavored wipe and dispensing system
WO2014132219A2 (fr) * 2013-02-28 2014-09-04 L'oreal Composition contenant un rébaudioside a et un tensioactif oxyéthyléné
FR3002443B1 (fr) * 2013-02-28 2019-08-02 L'oreal Composition contenant du rebaudioside a et un tensioactif oxyethylene
ITMI20131159A1 (it) * 2013-07-10 2015-01-11 Sinerga Group Srl Composizione cosmetica utile per il trattamento antieta' della pelle
FR3009960A1 (fr) * 2013-08-30 2015-03-06 Vabel Lab Composition anti-age a base de stevia
US20160287624A1 (en) * 2013-11-21 2016-10-06 Nestec S.A. Water-Soluble Vitamins to Increase Oral Absorption and Bioavailability
US9522929B2 (en) 2014-05-05 2016-12-20 Conagen Inc. Non-caloric sweetener
HUE051977T2 (hu) 2015-04-14 2021-04-28 Conagen Inc Kalóriamentes édesítõk elõállítása mesterséges egész sejtes katalizátorok használatával
KR102306041B1 (ko) * 2015-09-23 2021-09-27 주식회사 엘지생활건강 스테비오사이드를 유효성분으로 포함하는 피부 개선용 조성물
US9925229B1 (en) * 2015-10-15 2018-03-27 Paleo Life, Llc Anti-aging composition method
CN110769841A (zh) * 2017-06-13 2020-02-07 玫琳凯有限公司 化妆品组合物及其用于使皮肤紧致的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
JP3529811B2 (ja) * 1993-06-30 2004-05-24 三省製薬株式会社 皮膚外用剤
JPH08325156A (ja) 1995-06-01 1996-12-10 Ichimaru Pharcos Co Ltd ステビオール配糖体含有皮膚外用剤及び飲食品
AU2001279593A1 (en) 2001-02-01 2002-08-12 Soren Gregersen A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
JP2005035888A (ja) 2001-10-25 2005-02-10 Ta Stevia Co Ltd アナフィラキシー型アレルギー症状改善物質およびその製造方法
JP3759714B2 (ja) * 2001-12-27 2006-03-29 株式会社資生堂 幹細胞因子の産生・放出の抑制による掻痒、肌荒れ、敏感肌及び美白用薬剤
JP2003304846A (ja) * 2002-04-11 2003-10-28 Ts Aasu:Kk 飲料または食品
RU2409937C2 (ru) 2005-03-04 2011-01-27 Морита Кагаку Когио Со., Лтд. Растение с высоким содержанием ребаудиозида а
JP5571897B2 (ja) 2006-02-14 2014-08-13 株式会社ファンケル ビタミンｃトランスポーター産生促進剤
JP3935917B2 (ja) * 2006-03-17 2007-06-27 一丸ファルコス株式会社 ステビオール配糖体含有抗アレルギー剤
JP2008037758A (ja) * 2006-08-01 2008-02-21 Nippon Paper Chemicals Co Ltd マスキング剤
US8029846B2 (en) * 2007-03-14 2011-10-04 The Concentrate Manufacturing Company Of Ireland Beverage products
US20100099640A1 (en) 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
CA2686805C (fr) 2007-05-08 2015-11-24 Ajinomoto Co., Inc. Edulcorant comportant un recepteur du calcium
CN101062077B (zh) * 2007-06-18 2011-04-06 石任兵 一种同时制备甜叶菊总甜菊苷和甜叶菊总黄酮的方法
US20110038957A1 (en) 2007-12-03 2011-02-17 Ann Fowler Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof
WO2009126950A2 (fr) 2008-04-11 2009-10-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Glycosides de diterpène comme solubilisants naturels
PL2350110T3 (pl) * 2008-10-03 2016-12-30 Nowe glikozydy stewiolowe
WO2010150930A1 (fr) * 2009-06-25 2010-12-29 (주)벡스코아 Film à dissolution rapide administré par voie orale qui permet de prévenir efficacement tout goût désagréable
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
JP5599090B2 (ja) * 2009-12-16 2014-10-01 丸善製薬株式会社 Ｉ型コラーゲン産生促進剤
BR122021005304B1 (pt) * 2010-06-02 2022-02-22 Evolva, Inc Hospedeiro recombinante que compreende genes recombinantes para produção de esteviol ou glicosídeo de esteviol, ácido nucleico, método para produzir esteviol, glicosídeo de esteviol ou composição de glicosídeo de esteviol e método para sintetizar esteviol ou glicosídeo de esteviol
CN103732753B (zh) * 2011-08-08 2018-03-30 埃沃尔瓦公司 甜菊醇糖苷类的重组生产

Also Published As

Publication number Publication date
WO2013093881A1 (fr) 2013-06-27
EP2793821A1 (fr) 2014-10-29
US20150011493A1 (en) 2015-01-08
CN104125822A (zh) 2014-10-29
FR2984743A1 (fr) 2013-06-28
US9687434B2 (en) 2017-06-27
ES2901692T3 (es) 2022-03-23
CN104125822B (zh) 2018-02-06
EP2793821B1 (fr) 2021-10-13

Similar Documents

Publication Publication Date Title
FR2984743B1 (fr) Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.
MX2016005585A (es) Exopolisacarido para el tratamiento y/o el cuidado de la piel, medios de cultivo y composiciones del mismo.
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
MA35448B1 (fr) Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t
MX358978B (es) Exopolisacarido para el tratamiento y/o cuidado de piel, mucosas, cabello y/o uñas.
BR112014028017A2 (pt) composto, composição farmacêutica, método para tratar um distúrbio, método para reduzir a quantidade il-17 em um indivíduo e método para inibir a atividade de ror
AU2011328009A8 (en) Compounds and methods for treating pain
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
EA201201648A1 (ru) Стимуляторы sgc
NO20084024L (no) Imidazolbaserte forbindelser, preparater omfattende slike, og anvendelse av slike
MY184241A (en) Human antibodies to gfr?3 and methods of use thereof
MX2014001893A (es) Metodos para reducir el olor.
MY170143A (en) Robo2 inhibitory compositions comprising slit2-binding extracellular domain of robo2
WO2013102882A3 (fr) Utilisation cosmétique de cellules végétales dédifférenciées
NZ741785A (en) 3-cyano-1h-1,2,4-triazol-1-yl compounds and uses thereof for the treatment of hiv
WO2013006335A3 (fr) Méthodes et compositions utiles pour traiter des types de peau fitzpatrick iv, v ou vi
MX354697B (es) Composiciones de gel de brimonidina y métodos de uso.
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
SG10201909382UA (en) Glyt1 inhibitors for use in the treatment of hematological disorders
WO2014028668A3 (fr) Composés thérapeutiques activant les cellules souches
WO2013060707A3 (fr) Produits cosmétiques contenant de l'oxytocine et des substances odorantes
MX343517B (es) 2,4 pirimidinadiaminas sustituidas para su uso en lupus discoide.
IT1400837B1 (it) Metodo per la preparazione e uso di biocidi arricchiti in radicali attivi prima dell'uso.
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
FR2984735B1 (fr) Composition hydratante

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12